F&B M&A Disclosure: Advanced Medical Solutions Form 8.3 Filed
Regulatory filing indicates a disclosed interest in Advanced Medical Solutions Group amid an active offer period.
Regulatory filing indicates a disclosed interest in Advanced Medical Solutions Group amid an active offer period.
Proxy advisory giant ISS urges G2 shareholders to approve the deal at a special meeting scheduled for June 16, 2026.
The audio-tech firm reaches development benchmarks for its MCFN-OS platform ahead of a pending merger that could reshap…
The regulatory disclosure covers ordinary share dealings in the UK-listed property income trust — no food and beverage …
The source document is a UK regulatory Form 8.3 disclosure relating to Beazley PLC, a specialty insurer — outside F&B I…
A 403.2 million-vote quorum — 88.3% of eligible shares — ratified the full slate, including one new director.
The Pinky Cole Hayes-founded concept deepens its home-market footprint while entering the federal capital for the first…
The Northwest cooperative retains a long-term whey supply agreement with Actus, linking its Sunnyside, Wash. plant to t…
The deal adds a clinically validated, carrot-sourced prebiotic to Ingredion's functional ingredients portfolio as deman…
The deal links two family-aligned distributors across Alaska, Idaho, Oregon, and Washington with overlapping supplier p…
Proceeds from the GHS Investments financing were used to extinguish convertible notes held by 1800 Diagonal Lending, si…
Arends arrives from UTZ Brands, where he oversaw a $1.5 billion operation, and previously ran Kraft Heinz's $22 billion…